Latest Breaking News On - எல்ஜி செம் வாழ்க்கை அறிவியல் கண்டுபிடிப்பு மையம் - Page 1 : comparemela.com

LG Chem Life Sciences LG Chem Life Sciences Announces First Participant Dosed in First-in-Human Study of SSAO Inhibitor LG00303174 in the United States Tuesday, February 23, 2021 10:00AM IST (4:30AM GMT) First-In-Human Study Targeting the Endothelial Cell-expressed Adhesion Molecule VAP1   Nanjing, China & Seoul, South Korea & Cambridge, Mass., United States:   LG Chem Life Sciences (“LG Chem”) today announced the first healthy adult volunteer has been safely dosed in the phase I study of LG00303174 being run in the US.   LG Chem licensed LG00303174 (TT-01025) from TransThera Biosciences Co. Ltd. (“TransThera”), a clinical-stage biotechnology company based in Nanjing, China. LG Chem had entered into an exclusive license agreement with TransThera in August 2020 to research, develop, manufacture, and commercialize LG00303174 in the world except China and Japan.

China
Seoul
Soult-ukpyolsi
South-korea
Japan
United-states
Cambridge
Cambridgeshire
United-kingdom
Nanjing
Jiangsu
Transthera-biosciences